Why the study?
To investigate the contemporary status of stroke risk profile, antithrombotic treatment, and quality of life in Chinese patients with all types of AF.
Does anticoagulant treatment improve quality of life compared to no antithrombotic therapy in Chinese patients with atrial fibrillation?
Does anticoagulant treatment improve quality of life compared to no antithrombotic therapy in Chinese patients with atrial fibrillation?
In Chinese patients with atrial fibrillation, anticoagulant treatment is underused and antiplatelet treatment is overused, despite anticoagulation being associated with better quality of life.
No takes yet. Share an insight, caveat, or question.
Anticoagulant use was associated with better QoL domains in Chinese AF patients; hypothesis-generating and should not yet change practice.
Sun et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: